BIOMERIEUX (BIM.PA) Stock Analyst Earnings Estimates
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.376B 8.27% | 3.589B 6.31% | 3.675B 2.38% | 3.988B 8.53% | 4.287B 7.50% | 4.624B 7.86% | 5.035B 8.89% | 5.49B 9.04% | 4.825B -12.11% | 5.061B 4.89% | |
| EBITDA YoY % growth | 843.1M 10.41% | 654.2M -22.41% | 657.4M 0.49% | 919.72M 39.90% | 1.023B 11.23% | 1.153B 12.71% | 1.305B 13.18% | 1.462B 12.03% | N/A | N/A | |
| EBIT YoY % growth | 784.3M 41.88% | 587.2M -25.13% | 439M -25.24% | 626.46M 42.70% | 703.69M 12.33% | 796.99M 13.26% | 892.37M 11.97% | 1.04B 16.54% | 882.9M -15.11% | 928.52M 5.17% | |
| Operating Margin | 23.23% | 16.36% | 11.95% | 15.71% | 16.41% | 17.24% | 17.72% | 18.94% | 18.30% | 18.35% | |
| EPS YoY % growth | 5.08 48.97% | 3.82 -24.80% | N/A -3.16% | 4.14 11.79% | 4.62 11.77% | 5.24 13.38% | 6.13 17.01% | 6.94 13.25% | N/A | N/A |
All data in EUR
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | 2.07 |
| Revenue Q2Q % growth | 2.084B 9.42% |
| EBITDA Q2Q % growth | 474.7M 5.58% |
| EBIT Q2Q % growth | 335.32M 45.03% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 1.82 | 1.77 | 0.05 | 2.97% |
| Q4 2022 Q2Q % growth | 1.89 -31.27% | 2.18 | -0.29 | -13.37% |
| Q2 2022 Q2Q % growth | 1.93 -17.17% | 2.24 | -0.31 | -13.92% |
| Q4 2021 Q2Q % growth | 2.75 41.03% | 2.37 | 0.38 | 15.86% |
| Q2 2021 Q2Q % growth | 2.33 59.59% | 2.02 | 0.31 | 15.35% |
| Q4 2020 Q2Q % growth | 1.95 74.11% | 2.08 | -0.13 | -6.28% |
| Q2 2020 Q2Q % growth | 1.46 23.73% | 1.42 | 0.04 | 2.52% |
| Q4 2019 Q2Q % growth | 1.12 | 1.17 | -0.05 | -4.40% |
| Q2 2019 Q2Q % growth | 1.18 | 1.12 | 0.06 | 5.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 1.902B 7.45% | 1.897B | 4.9M | 0.26% |
| Q4 2023 Q2Q % growth | 1.905B -1.37% | % | ||
| Q2 2023 Q2Q % growth | 1.77B 6.76% | % | ||
| Q4 2022 Q2Q % growth | 1.931B 7.16% | 1.95B | -18.9M | -0.97% |
| Q2 2022 Q2Q % growth | 1.658B 5.32% | 1.724B | -66M | -3.83% |
| Q4 2021 Q2Q % growth | 1.802B 9.74% | 1.792B | 10M | 0.56% |
| Q2 2021 Q2Q % growth | 1.574B 6.64% | 1.611B | -36.8M | -2.28% |
| Q4 2020 Q2Q % growth | 1.642B 17.31% | 1.627B | 15M | 0.92% |
| Q2 2020 Q2Q % growth | 1.476B 15.77% | 1.533B | -56.8M | -3.71% |
| Q4 2019 Q2Q % growth | 1.4B | 1.41B | -10.3M | -0.73% |
| Q2 2019 Q2Q % growth | 1.275B | 1.271B | 4.1M | 0.32% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 3.75% |
| Revenue | N/A | N/A | 0.23% | 0.48% |